MA29451B1 - Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme - Google Patents
Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludismeInfo
- Publication number
- MA29451B1 MA29451B1 MA30375A MA30375A MA29451B1 MA 29451 B1 MA29451 B1 MA 29451B1 MA 30375 A MA30375 A MA 30375A MA 30375 A MA30375 A MA 30375A MA 29451 B1 MA29451 B1 MA 29451B1
- Authority
- MA
- Morocco
- Prior art keywords
- malaria
- treatment
- ferroquin
- association
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
L'INVENTION A POUR OBJET UNE ASSOCIATION, QUI COMPREND DE LA FERROQUINE, SOUS FORME DE BASE LIBRE, DE SEL, D'HYDRATE OU DE SOLVAT, ET UN DÉRIVÉ D'ARTÉMISININE. L'INVENTION A ÉGALEMENT POUR OBJET UNE COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA FERROQUINE, SOUS FORME D'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, D'UN HYDRATE OU D'UN SOLVAT DE LA FERROQUINE, ET D'AU MOINS UN DÉRIVÉ D'ARTÉMISININE. L'INVENTION A AUSSI POUR OBJET L'UTILISATION D'UNE TELLE ASSOCIATION POUR LA PRÉPARATION D'UN MÉDICAMENT DESTINÉ AU TRAITEMENT OU À LA PRÉVENTION DU PALUDISME. L'INVENTION A ENFIN POUR OBJET UN KIT POUR LE TRAITEMENT OU LA PRÉVENTION DU PALUDISME.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503932A FR2884715B1 (fr) | 2005-04-20 | 2005-04-20 | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29451B1 true MA29451B1 (fr) | 2008-05-02 |
Family
ID=35385843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30375A MA29451B1 (fr) | 2005-04-20 | 2007-11-19 | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
Country Status (30)
Country | Link |
---|---|
US (1) | US20120258945A1 (fr) |
EP (1) | EP1874293A1 (fr) |
JP (1) | JP5148478B2 (fr) |
KR (1) | KR20080009088A (fr) |
CN (2) | CN102836163A (fr) |
AP (1) | AP2782A (fr) |
AR (1) | AR054253A1 (fr) |
AU (1) | AU2006238506B2 (fr) |
BR (1) | BRPI0610851A2 (fr) |
CA (1) | CA2605385A1 (fr) |
CR (1) | CR9425A (fr) |
DO (1) | DOP2006000092A (fr) |
EA (1) | EA012630B1 (fr) |
FR (1) | FR2884715B1 (fr) |
GT (1) | GT200600157A (fr) |
HN (1) | HN2006015130A (fr) |
IL (1) | IL186048A0 (fr) |
MA (1) | MA29451B1 (fr) |
MX (1) | MX2007012645A (fr) |
MY (1) | MY145581A (fr) |
NO (1) | NO20075920L (fr) |
NZ (1) | NZ562117A (fr) |
PA (1) | PA8669801A1 (fr) |
PE (2) | PE20061314A1 (fr) |
SG (1) | SG161270A1 (fr) |
TN (1) | TNSN07359A1 (fr) |
TW (1) | TWI387456B (fr) |
UA (1) | UA96414C2 (fr) |
WO (1) | WO2006111647A1 (fr) |
ZA (1) | ZA200708800B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926993B1 (fr) * | 2008-02-06 | 2011-03-11 | Sanofi Aventis | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme |
FR2952823B1 (fr) * | 2009-10-30 | 2012-04-20 | Sanofi Aventis | Utilisation de la ferroquine dans le traitement ou la prevention du paludisme |
FR2951945B1 (fr) * | 2009-11-05 | 2013-08-09 | Sanofi Aventis | Composition pharmaceutique |
FR2961209B1 (fr) * | 2010-06-11 | 2013-03-01 | Sanofi Aventis | Procede de synthese de la ferroquine par amination reductrice convergente. |
FR2989588A1 (fr) * | 2012-04-19 | 2013-10-25 | Centre Nat Rech Scient | Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae |
CA2928866C (fr) | 2013-11-08 | 2021-11-09 | Exthera Medical Corporation | Procedes pour diagnostiquer des maladies infectieuses a l'aide de milieux d'adsorption |
CN105250295B (zh) * | 2014-07-07 | 2018-12-25 | 广州中医药大学科技产业园有限公司 | 一种联合用药物及其作为免疫调节剂的应用 |
US10512652B2 (en) | 2015-07-20 | 2019-12-24 | University Of Vermont And State Agricultural College | Use of cymanquine compounds as antimalarial agents |
CN107802755A (zh) * | 2017-11-08 | 2018-03-16 | 江西龙卿堂科技有限公司 | 一种具有防蚊防疟作用的青蒿软膏 |
KR102073961B1 (ko) * | 2018-11-16 | 2020-02-05 | (주)프론트바이오 | 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 |
WO2022231238A1 (fr) * | 2021-04-26 | 2022-11-03 | 심민보 | Composition pharmaceutique contenant de l'artésunate ou un sel de celui-ci et de la pyronaridine ou un sel de celle-ci, utilisée à des fins antipyrétiques, anti-inflammatoires, antivirales et pour le traitement ou la prévention de la covid-19, et procédé l'utilisant |
CN113952360B (zh) * | 2021-09-14 | 2023-03-10 | 上海交通大学 | 一种亚铁离子在治疗疟疾的药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN166154B (fr) * | 1987-05-08 | 1990-03-24 | Hoechst India | |
AP2006003557A0 (en) * | 2003-09-04 | 2006-04-30 | Cipla Ltd | Antimalarial compositions and process thereof. |
-
2005
- 2005-04-20 FR FR0503932A patent/FR2884715B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-17 PE PE2006000399A patent/PE20061314A1/es not_active Application Discontinuation
- 2006-04-17 PE PE2010000537A patent/PE20110119A1/es not_active Application Discontinuation
- 2006-04-18 EA EA200702282A patent/EA012630B1/ru not_active IP Right Cessation
- 2006-04-18 SG SG201002562-5A patent/SG161270A1/en unknown
- 2006-04-18 MX MX2007012645A patent/MX2007012645A/es active IP Right Grant
- 2006-04-18 AP AP2007004211A patent/AP2782A/xx active
- 2006-04-18 JP JP2008507122A patent/JP5148478B2/ja not_active Expired - Fee Related
- 2006-04-18 AU AU2006238506A patent/AU2006238506B2/en not_active Ceased
- 2006-04-18 ZA ZA200708800A patent/ZA200708800B/xx unknown
- 2006-04-18 MY MYPI20061772A patent/MY145581A/en unknown
- 2006-04-18 CA CA002605385A patent/CA2605385A1/fr not_active Abandoned
- 2006-04-18 WO PCT/FR2006/000842 patent/WO2006111647A1/fr active Application Filing
- 2006-04-18 EP EP06743711A patent/EP1874293A1/fr not_active Withdrawn
- 2006-04-18 BR BRPI0610851-2A patent/BRPI0610851A2/pt not_active IP Right Cessation
- 2006-04-18 KR KR1020077024076A patent/KR20080009088A/ko active IP Right Grant
- 2006-04-18 NZ NZ562117A patent/NZ562117A/en not_active IP Right Cessation
- 2006-04-18 UA UAA200712809A patent/UA96414C2/ru unknown
- 2006-04-18 CN CN201210369240XA patent/CN102836163A/zh active Pending
- 2006-04-18 CN CNA2006800130136A patent/CN101163470A/zh active Pending
- 2006-04-19 AR AR20060101538A patent/AR054253A1/es unknown
- 2006-04-19 PA PA20068669801A patent/PA8669801A1/es unknown
- 2006-04-20 GT GT200600157A patent/GT200600157A/es unknown
- 2006-04-20 DO DO2006000092A patent/DOP2006000092A/es unknown
- 2006-04-20 HN HN2006015130A patent/HN2006015130A/es unknown
- 2006-04-20 TW TW095114167A patent/TWI387456B/zh not_active IP Right Cessation
-
2007
- 2007-09-18 IL IL186048A patent/IL186048A0/en unknown
- 2007-09-21 TN TNP2007000359A patent/TNSN07359A1/en unknown
- 2007-10-08 CR CR9425A patent/CR9425A/es unknown
- 2007-10-18 US US11/874,377 patent/US20120258945A1/en not_active Abandoned
- 2007-11-16 NO NO20075920A patent/NO20075920L/no not_active Application Discontinuation
- 2007-11-19 MA MA30375A patent/MA29451B1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29451B1 (fr) | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme | |
MA29550B1 (fr) | Derives de n- (pyridine-2-yl) - sulfonamide | |
LU92853I2 (fr) | Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégée par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine et l'emtricitabine | |
PL373903A1 (en) | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease | |
ATE449081T1 (de) | Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen | |
MX9801305A (es) | Composicion de disolucion rapida oral para agonistas de dopamina. | |
BRPI0409125A (pt) | terapia de combinação para constipação compreendendo um laxativo e um antagonista de opióide periférico | |
HUP0301194A2 (hu) | Dipeptidil-peptidáz IV. inhibitorokból és más antidiabetikus szerekből álló kombinációs készítmények és alkalmazásuk diabetes mellitus kezelésére | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MA29744B1 (fr) | Formulations posologiques solides de medicaments presentant une adsorption buccale amelioree | |
WO2004047838A3 (fr) | Composition pharmaceutique a base d'agonistes des recepteurs beta-3-adrenergiques et d'antimuscariniques | |
MY148125A (en) | Compounds | |
MA29871B1 (fr) | Composition pharmaceutique concue pour ameliorer la fonction cognitive | |
EP1201268A3 (fr) | Compositions pharmaceutiques contenant des antagonistes du récepteur D4 de dopamine et des inhibiteurs de l' Acetylcholinesterase | |
BG105302A (en) | Means for improving cognition | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
EP1254668A3 (fr) | Combinaison d'un inhibiteur de la recapture de la sérotonine et d'un GABA-A alpha 2/3 agoniste pour l'utilisation dans l'anxiété et la dépression | |
BR0206819A (pt) | Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca | |
PA8552301A1 (es) | Metodo para el tratamiento de insomnio primario | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
DE60008590D1 (de) | Zusammensetzungen von adenosin a1 agonisten und cox2-hemmern | |
DE60014429D1 (de) | Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten | |
HUP0004461A2 (hu) | Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények |